AUTHORS
Daniel Petersheim, MD PhD, Christopher Radtke2, Mehmet T Kiziltug3, Janina Kroll, PhD4, Almke Bader, PhD5, Julia Krebs6, Johanna Schmid7, Daniela Maier-Begandt, PhD8, Barbara Walzog, PhD9, Jörg Renkawitz, PhD10, Monika Linder, PhD11, Christoph Klein V, MD12
AFFILIATIONS
1 German Center for Child and Adolescent Health (DZKJ), Munich, Germany, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany
2 LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany
3 LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany
4 Ludwig-Maximilians-Universität München, Munich, Germany
5 Ludwig-Maximilians-Universität München, Munich, Germany
6 LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany
7 Ludwig-Maximilians-Universität München, Munich, Germany
8 Ludwig-Maximilians-Universität München, Munich, Germany
9 Ludwig-Maximilians-Universität München, Munich, Germany
10 Ludwig-Maximilians-Universität München, Munich, Germany
11 LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany
12 German Center for Child and Adolescent Health (DZKJ), Munich, Germany, LMU University Hospital, LMU Medizin, Ludwig-Maximilians-Universität München, Munich, Germany, Ludwig-Maximilians-Universität München, Munich, Germany
ABSTRACT
Understanding the molecular programs that govern immune cell differentiation, activation, and functional plasticity requires approaches that quantitatively resolve endogenous protein abundance, localization, and dynamics while preserving physiological gene regulation throughout differentiation.
We recently reported a differentiation-compatible platform for dual-color endogenous gene tagging in human induced pluripotent stem cells (iPSCs) using orthogonal split fluorescent proteins (FPs), enabling cell type-specific analysis of protein dynamics in iPSC-derived hematopoietic cells. The platform combines pre-engineered master iPSCs that maintain FP1–10 expression throughout differentiation with minimally disruptive FP11 tags inserted into endogenous target loci, keeping tagged proteins under native transcriptional control. Consistent with this design, expression levels of FP11-tagged proteins were comparable to those of the corresponding untagged proteins in both undifferentiated iPSCs and iPSC-derived neutrophils. This was observed for targets associated with diverse subcellular structures, including the nuclear lamina (LMNB1), chromatin (H2BC11), microtubules (TUBA1B and TUBB4B), mitochondria (TOMM20), and the endoplasmic reticulum (SEC61B), indicating that FP11 tagging does not perturb physiological protein expression.
Here, we use this platform to resolve endogenous protein dynamics across defined stages of neutrophil differentiation (proNEUs, preNEUs, immatureNEUs, and matureNEUs; gated as previously described), revealing distinct, tightly regulated expression trajectories. For instance, in mNG211-LMNB1 iPSC-derived cells, mNeonGreen2 (mNG2) fluorescence intensity was highest in proNEUs and immatureNEUs and declined in matureNEUs, consistent with reduced Lamin B1 expression in peripheral blood neutrophils. In mNG211-LMNB1/H2BC11-sfCherry311 iPSC-derived cells, sfCherry3 fluorescence intensity peaked sharply in CD35low immatureNEU1s (9.3-fold over preNEUs), coinciding with cell-cycle exit of myeloid progenitors and activation of a neutrophil-specific transcriptional program. In both mNG211-TUBA1B and mNG211-TUBB4B iPSC-derived cells, mNG2 fluorescence intensity declined prior to terminal differentiation. Together, these findings establish split FP tagging as a quantitative approach for profiling endogenous protein abundance at single-cell resolution throughout human granulopoiesis.
Having previously used mNG211-LMNB1 iPSC-derived neutrophils to visualize nuclear remodeling during NETosis, we next asked whether our reporters could resolve defects in nuclear morphogenesis during granulocytic differentiation. Lamin B receptor (LBR) is closely linked to the acquisition of the multilobed nuclear morphology of mature neutrophils, and mutations that reduce LBR levels cause autosomal-dominant Pelger–Huët anomaly (PHA), which is characterized by nuclear hypolobulation. We therefore introduced the PHA-associated LBR splice acceptor variant IVS12-5-10del in the heterozygous (LBRHet) or homozygous (LBRHom) state into mNG211-LMNB1/H2BC11-sfCherry311 iPSCs. Differentiation of both mutant lines yielded maturation profiles comparable to that of the control line (LBRWT), indicating that reduced LBR expression does not impair acquisition of a mature neutrophil immunophenotype. Giemsa-stained cytospins of FACS-purified matureNEUs and live-cell confocal imaging revealed a graded defect in nuclear architecture, with multilobed nuclei (≥ 3 lobes) observed in 71%, 16%, and 7% of LBRWT, LBRHet, and LBRHom neutrophils, respectively (n ≥ 200 cells per genotype). LBRHet nuclei were predominantly bilobed and pelgeroid, whereas LBRHom nuclei were largely round and non-segmented, with coarse, densely compacted chromatin. These findings confirm a dosage-dependent requirement for LBR in neutrophil nuclear segmentation and demonstrate that split FP reporter iPSCs can be combined with genome editing to model inherited defects of nuclear architecture and chromatin organization.
By combining endogenous protein tagging, live-cell imaging, directed differentiation, and genome editing within a single platform, our approach enables mechanistic dissection of human hematopoietic development and complements transcriptomic and proteomic atlases with spatially and temporally resolved measurements in living cells.
DISCLOSURES
Daniel Petersheim, MD PhD: No relevant conflicts of interest to declare.